Title: Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Journal: Oncotarget 20160920
Title: CB2 receptor activation ameliorates the proinflammatory activity in acute lung injury induced by paraquat.
Journal: BioMed research international 20140101
Title: Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Journal: Journal of medicinal chemistry 20131114
Title: Cannabinoid agonists increase the interaction between β-Arrestin 2 and ERK1/2 and upregulate β-Arrestin 2 and 5-HT(2A) receptors.
Journal: Pharmacological research 20130201
Title: Cannabinoid-induced enhanced interaction and protein levels of serotonin 5-HT(2A) and dopamine D₂ receptors in rat prefrontal cortex.
Journal: Journal of psychopharmacology (Oxford, England) 20121001
Title: Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists.
Journal: Journal of medicinal chemistry 20120614
Title: Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.
Journal: European journal of medicinal chemistry 20120601
Title: The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
Journal: European heart journal 20120401
Title: Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20120321
Title: Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
Journal: Toxicology and applied pharmacology 20120115
Title: Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice.
Journal: Journal of neuroinflammation 20120101
Title: Discovery and optimization of 1-(4-(pyridin-2-yl)benzyl)imidazolidine-2,4-dione derivatives as a novel class of selective cannabinoid CB2 receptor agonists.
Journal: Journal of medicinal chemistry 20111027
Title: Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
Journal: European journal of pharmacology 20111001
Title: Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.
Journal: Bioorganic & medicinal chemistry 20110915
Title: Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice.
Journal: Nature neuroscience 20110901
Title: Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways.
Journal: British journal of pharmacology 20110801
Title: The endocannabinoid system in rat gliosomes and its role in the modulation of glutamate release.
Journal: Cellular and molecular life sciences : CMLS 20110301
Title: Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Journal: European journal of medicinal chemistry 20110201
Title: Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization.
Journal: Blood 20110120
Title: Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice.
Journal: PloS one 20110101
Title: Evaluation of cannabinoid receptor 2 and metabotropic glutamate receptor 1 functional responses using a cell impedance-based technology.
Journal: Journal of biomolecular screening 20101201
Title: 1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.
Journal: Bioorganic & medicinal chemistry 20101115
Title: Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration.
Journal: Hepatology (Baltimore, Md.) 20100901
Title: Emerging targets in osteoporosis disease modification.
Journal: Journal of medicinal chemistry 20100610
Title: Involvement of cannabinoid-1 and cannabinoid-2 receptors in septic ileus.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100301
Title: Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis.
Journal: Inflammatory bowel diseases 20091101
Title: Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Journal: Molecular cancer therapeutics 20091101
Title: Constitutive activity of cannabinoid-2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242.
Journal: British journal of pharmacology 20090901
Title: Functional CB2 type cannabinoid receptors at CNS synapses.
Journal: Neuropharmacology 20090901
Title: Rational design, synthesis, and pharmacological properties of new 1,8-naphthyridin-2(1H)-on-3-carboxamide derivatives as highly selective cannabinoid-2 receptor agonists.
Journal: Journal of medicinal chemistry 20090625
Title: CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion.
Journal: Journal of molecular and cellular cardiology 20090501
Title: CB1 cannabinoid receptor-dependent and -independent inhibition of depolarization-induced calcium influx in oligodendrocytes.
Journal: Glia 20090201
Title: Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis.
Journal: PloS one 20090101
Title: The preventive effect of cannabinoids on reperfusion-induced ischemia of mouse kidney.
Journal: Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie 20080801
Title: Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
Journal: European journal of pharmacology 20080317
Title: Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.
Journal: Cancer research 20080315
Title: Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats.
Journal: The Journal of pharmacology and experimental therapeutics 20080201
Title: Down-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?
Journal: Neuropharmacology 20080101
Title: Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
Journal: Journal of neuroimmunology 20080101
Title: Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
Journal: European journal of pharmacology 20071114
Title: Influence of nicotinic receptor modulators on CB2 cannabinoid receptor agonist (JWH133)-induced antinociception in mice.
Journal: Behavioural pharmacology 20071101
Title: Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.
Journal: Journal of medicinal chemistry 20071101
Title: Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis.
Journal: Journal of leukocyte biology 20070901
Title: Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Journal: Pharmacological research 20070901
Title: Mechanisms for the coupling of cannabinoid receptors to intracellular calcium mobilization in rat insulinoma beta-cells.
Journal: Experimental cell research 20070815
Title: Temporal variation in CB2R levels following T lymphocyte activation: evidence that cannabinoids modulate CXCL12-induced chemotaxis.
Journal: International immunopharmacology 20070301
Title: Design, synthesis, and biological evaluation of new 1,8-naphthyridin-4(1H)-on-3-carboxamide and quinolin-4(1H)-on-3-carboxamide derivatives as CB2 selective agonists.
Journal: Journal of medicinal chemistry 20061005
Title: Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium.
Journal: American journal of physiology. Gastrointestinal and liver physiology 20060801
Title: Novel 4-oxo-1,4-dihydroquinoline-3-carboxamide derivatives as new CB2 cannabinoid receptors agonists: synthesis, pharmacological properties and molecular modeling.
Journal: Journal of medicinal chemistry 20060112
Title: The cannabinoid CB2 receptor selective agonist JWH133 reduces mast cell oedema in response to compound 48/80 in vivo but not the release of beta-hexosaminidase from skin slices in vitro.
Journal: Life sciences 20060102
Title: Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat.
Journal: Pain 20051205
Title: Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
Journal: The European journal of neuroscience 20050701
Title: Activation of cannabinoid CB2 receptor negatively regulates IL-12p40 production in murine macrophages: role of IL-10 and ERK1/2 kinase signaling.
Journal: British journal of pharmacology 20050601
Title: Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20050223
Title: Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
Journal: The European journal of neuroscience 20041101
Title: Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Journal: Cancer research 20040815
Title: Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes.
Journal: Cancer immunology, immunotherapy : CII 20040801
Title: Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
Journal: Anesthesiology 20030901
Title: Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.
Journal: British journal of pharmacology 20030901
Title: Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits.
Journal: Life sciences 20030103
Title: Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
Journal: The Journal of clinical investigation 20030101
Title: Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
Journal: Cancer research 20010801
Title: Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development.
Journal: Expert opinion on investigational drugs 20000701
Title: 3-(1',1'-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor.
Journal: Bioorganic & medicinal chemistry 19991201
